$LPRO
Open Lending Corp

2021 Q1 Form 10-Q Financial Statement

#000162828021010361 Filed on May 14, 2021

View on sec.gov

Income Statement

Concept 2021 Q1 2020 Q1
Revenue $44.01M $17.43M
YoY Change 152.48% -10.54%
Cost Of Revenue $3.362M $2.495M
YoY Change 34.75%
Gross Profit $40.65M $14.94M
YoY Change 172.15% -16.83%
Gross Profit Margin 92.36% 85.69%
Selling, General & Admin $10.61M $5.647M
YoY Change 87.87% 3664.67%
% of Gross Profit 26.1% 37.81%
Research & Development $591.0K $359.0K
YoY Change 64.62%
% of Gross Profit 1.45% 2.4%
Depreciation & Amortization $388.0K $27.00K
YoY Change 1337.04%
% of Gross Profit 0.95% 0.18%
Operating Expenses $11.20M $6.006M
YoY Change 86.48% 3904.0%
Operating Profit $29.45M $8.929M
YoY Change 229.78% -30.58%
Interest Expense $3.289M $764.0K
YoY Change 330.5% -49.74%
% of Operating Profit 11.17% 8.56%
Other Income/Expense, Net -$131.0K $1.000K
YoY Change -13200.0%
Pretax Income $17.33M $8.183M
YoY Change 111.8% 497.3%
Income Tax $4.500M $11.00K
% Of Pretax Income 25.96% 0.13%
Net Earnings $12.86M $8.172M
YoY Change 57.39% -36.67%
Net Earnings / Revenue 29.23% 46.88%
Basic Earnings Per Share $0.10 $0.40
Diluted Earnings Per Share $0.10 $0.16
COMMON SHARES
Basic Shares Outstanding 126.8M shares 37.63M shares
Diluted Shares Outstanding 126.8M shares 51.91M shares

Balance Sheet

Concept 2021 Q1 2020 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $127.0M $600.0K
YoY Change 21066.67% -40.0%
Cash & Equivalents $127.0M $40.31M
Short-Term Investments
Other Short-Term Assets $980.0K $100.0K
YoY Change 880.0% 0.0%
Inventory
Prepaid Expenses $932.0K
Receivables $6.803M
Other Receivables $0.00
Total Short-Term Assets $191.1M $700.0K
YoY Change 27199.0% -36.36%
LONG-TERM ASSETS
Property, Plant & Equipment $1.608M
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $282.3M
YoY Change 0.97%
Other Assets $124.0K
YoY Change
Total Long-Term Assets $135.7M $282.3M
YoY Change -51.93% 0.97%
TOTAL ASSETS
Total Short-Term Assets $191.1M $700.0K
Total Long-Term Assets $135.7M $282.3M
Total Assets $326.8M $283.0M
YoY Change 15.48% 0.82%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.991M $900.0K
YoY Change 232.33%
Accrued Expenses $3.994M $200.0K
YoY Change 1897.0%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $3.125M
YoY Change
Total Short-Term Liabilities $19.01M $1.400M
YoY Change 1257.86% 180.0%
LONG-TERM LIABILITIES
Long-Term Debt $170.2M $0.00
YoY Change
Other Long-Term Liabilities $92.37M $9.600M
YoY Change 862.18% 0.0%
Total Long-Term Liabilities $262.6M $9.600M
YoY Change 2635.22% 0.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $19.01M $1.400M
Total Long-Term Liabilities $262.6M $9.600M
Total Liabilities $286.6M $11.00M
YoY Change 2505.55% 8.91%
SHAREHOLDERS EQUITY
Retained Earnings -$415.5M
YoY Change
Common Stock $1.282M
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost) $37.50M
YoY Change
Treasury Stock Shares 1.395M shares
Shareholders Equity $40.19M -$314.0M
YoY Change
Total Liabilities & Shareholders Equity $326.8M $283.0M
YoY Change 15.48% 0.82%

Cashflow Statement

Concept 2021 Q1 2020 Q1
OPERATING ACTIVITIES
Net Income $12.86M $8.172M
YoY Change 57.39% -36.67%
Depreciation, Depletion And Amortization $388.0K $27.00K
YoY Change 1337.04%
Cash From Operating Activities $18.84M $7.075M
YoY Change 166.22% -1745.35%
INVESTING ACTIVITIES
Capital Expenditures $3.000K $83.00K
YoY Change -96.39%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$3.000K -$83.00K
YoY Change -96.39% -141.5%
FINANCING ACTIVITIES
Cash Dividend Paid $0.00 $134.2M
YoY Change -100.0%
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $6.662M $23.42M
YoY Change -71.56%
NET CHANGE
Cash From Operating Activities $18.84M $7.075M
Cash From Investing Activities -$3.000K -$83.00K
Cash From Financing Activities $6.662M $23.42M
Net Change In Cash $25.49M $30.41M
YoY Change -16.18% -13323.48%
FREE CASH FLOW
Cash From Operating Activities $18.84M $7.075M
Capital Expenditures $3.000K $83.00K
Free Cash Flow $18.83M $6.992M
YoY Change 169.34%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q1 dei Amendment Flag
AmendmentFlag
false
CY2021Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
CY2021Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2021Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001806201
CY2021Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2021Q1 dei Document Type
DocumentType
10-Q
CY2021Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2021Q1 dei Document Period End Date
DocumentPeriodEndDate
2021-03-31
CY2021Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2021Q1 dei Entity File Number
EntityFileNumber
001-39326
CY2021Q1 dei Entity Registrant Name
EntityRegistrantName
OPEN LENDING CORPORATION
CY2021Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2021Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
84-5031428
CY2021Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
1501 S. MoPac Expressway
CY2021Q1 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 450
CY2021Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Austin
CY2021Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
TX
CY2021Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
78746
CY2021Q1 dei City Area Code
CityAreaCode
512
CY2021Q1 dei Local Phone Number
LocalPhoneNumber
892-0400
CY2021Q1 dei Security12b Title
Security12bTitle
Common stock, par value $0.01 per share
CY2021Q1 dei Trading Symbol
TradingSymbol
LPRO
CY2021Q1 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2021Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2021Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2021Q1 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2021Q1 dei Entity Small Business
EntitySmallBusiness
false
CY2021Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2021Q1 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2021Q1 dei Entity Shell Company
EntityShellCompany
false
CY2021Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
126190351 shares
CY2021Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
127011000 USD
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
101513000 USD
CY2021Q1 us-gaap Restricted Cash Current
RestrictedCashCurrent
2631000 USD
CY2020Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
2635000 USD
CY2021Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
6803000 USD
CY2020Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
4352000 USD
CY2021Q1 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
52736000 USD
CY2020Q4 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
50386000 USD
CY2021Q1 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
932000 USD
CY2020Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
1873000 USD
CY2021Q1 us-gaap Other Assets Current
OtherAssetsCurrent
980000 USD
CY2020Q4 us-gaap Other Assets Current
OtherAssetsCurrent
2018000 USD
CY2021Q1 us-gaap Assets Current
AssetsCurrent
191093000 USD
CY2020Q4 us-gaap Assets Current
AssetsCurrent
162777000 USD
CY2021Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1608000 USD
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1201000 USD
CY2021Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
5600000 USD
CY2020Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
5733000 USD
CY2021Q1 us-gaap Contract With Customer Asset Net Noncurrent
ContractWithCustomerAssetNetNoncurrent
44482000 USD
CY2020Q4 us-gaap Contract With Customer Asset Net Noncurrent
ContractWithCustomerAssetNetNoncurrent
38956000 USD
CY2021Q1 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
83888000 USD
CY2020Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
85218000 USD
CY2021Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
124000 USD
CY2020Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
124000 USD
CY2021Q1 us-gaap Assets
Assets
326795000 USD
CY2020Q4 us-gaap Assets
Assets
294009000 USD
CY2021Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
2991000 USD
CY2020Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
3442000 USD
CY2021Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
3994000 USD
CY2020Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
3033000 USD
CY2021Q1 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
4791000 USD
CY2020Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
1640000 USD
CY2021Q1 us-gaap Notes Payable Current
NotesPayableCurrent
3125000 USD
CY2020Q4 us-gaap Notes Payable Current
NotesPayableCurrent
4888000 USD
CY2021Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
4109000 USD
CY2020Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
4005000 USD
CY2021Q1 us-gaap Liabilities Current
LiabilitiesCurrent
19010000 USD
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
17008000 USD
CY2021Q1 us-gaap Long Term Notes Payable
LongTermNotesPayable
170212000 USD
CY2020Q4 us-gaap Long Term Notes Payable
LongTermNotesPayable
152859000 USD
CY2021Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
5019000 USD
CY2020Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
5138000 USD
CY2021Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
92369000 USD
CY2020Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
92382000 USD
CY2021Q1 us-gaap Liabilities
Liabilities
286610000 USD
CY2020Q4 us-gaap Liabilities
Liabilities
267387000 USD
CY2021Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2021Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2020Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2020Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2021Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2020Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2021Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2021Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2020Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2021Q1 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2020Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2021Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
550000000 shares
CY2021Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
550000000 shares
CY2021Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
128198185 shares
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
128198185 shares
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
126803096 shares
CY2021Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
126803096 shares
CY2021Q1 us-gaap Common Stock Value
CommonStockValue
1282000 USD
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
1282000 USD
CY2021Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
491947000 USD
CY2020Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
491246000 USD
CY2021Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-415544000 USD
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-428406000 USD
CY2021Q1 us-gaap Treasury Stock Shares
TreasuryStockShares
1395089 shares
CY2020Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
1395089 shares
CY2021Q1 us-gaap Treasury Stock Value
TreasuryStockValue
37500000 USD
CY2020Q4 us-gaap Treasury Stock Value
TreasuryStockValue
37500000 USD
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
40185000 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
26622000 USD
CY2021Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
326795000 USD
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
294009000 USD
CY2021Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
44008000 USD
CY2020Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
17430000 USD
CY2021Q1 us-gaap Cost Of Revenue
CostOfRevenue
3362000 USD
CY2020Q1 us-gaap Cost Of Revenue
CostOfRevenue
2495000 USD
CY2021Q1 us-gaap Gross Profit
GrossProfit
40646000 USD
CY2020Q1 us-gaap Gross Profit
GrossProfit
14935000 USD
CY2021Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
8212000 USD
CY2020Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3569000 USD
CY2021Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
2397000 USD
CY2020Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
2078000 USD
CY2021Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
591000 USD
CY2020Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
359000 USD
CY2021Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
29446000 USD
CY2020Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
8929000 USD
CY2021Q1 us-gaap Interest Expense
InterestExpense
3289000 USD
CY2020Q1 us-gaap Interest Expense
InterestExpense
764000 USD
CY2021Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
84000 USD
CY2020Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
17000 USD
CY2021Q1 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-8778000 USD
CY2020Q1 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 USD
CY2020Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1000 USD
CY2021Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-131000 USD
CY2021Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
17332000 USD
CY2020Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
8183000 USD
CY2021Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
4470000 USD
CY2020Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
11000 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
12862000 USD
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
8172000 USD
CY2021Q1 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
0 USD
CY2020Q1 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
40475000 USD
CY2021Q1 lpro Noncash Adjustment To Redemption Amount Of The Redeemable Convertible Preferred Units
NoncashAdjustmentToRedemptionAmountOfTheRedeemableConvertiblePreferredUnits
0 USD
CY2020Q1 lpro Noncash Adjustment To Redemption Amount Of The Redeemable Convertible Preferred Units
NoncashAdjustmentToRedemptionAmountOfTheRedeemableConvertiblePreferredUnits
-47537000 USD
CY2021Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
12862000 USD
CY2020Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
15234000 USD
CY2021Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.10
CY2020Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.40
CY2021Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.10
CY2020Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.16
CY2021Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
126803096 shares
CY2020Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
37631052 shares
CY2021Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
126837832 shares
CY2020Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
51909655 shares
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
26622000 USD
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
701000 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
12862000 USD
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
40185000 USD
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
-234779000 USD
CY2020Q1 lpro Fair Value Adjustment Of Redemption Option
FairValueAdjustmentOfRedemptionOption
47537000 USD
CY2020Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
487000 USD
CY2020Q1 us-gaap Dividends
Dividends
135380000 USD
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
8172000 USD
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
-313963000 USD
CY2021Q1 us-gaap Increase Decrease In Deferred Charges
IncreaseDecreaseInDeferredCharges
0 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
12862000 USD
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
8172000 USD
CY2021Q1 us-gaap Share Based Compensation
ShareBasedCompensation
701000 USD
CY2021Q1 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
134000 USD
CY2020Q1 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
95000 USD
CY2020Q1 us-gaap Share Based Compensation
ShareBasedCompensation
487000 USD
CY2021Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
388000 USD
CY2020Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
27000 USD
CY2021Q1 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-8778000 USD
CY2020Q1 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 USD
CY2021Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
1330000 USD
CY2020Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
0 USD
CY2021Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
2451000 USD
CY2020Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
1092000 USD
CY2021Q1 us-gaap Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
7876000 USD
CY2020Q1 us-gaap Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
-4202000 USD
CY2021Q1 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-941000 USD
CY2020Q1 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
178000 USD
CY2020Q1 us-gaap Increase Decrease In Deferred Charges
IncreaseDecreaseInDeferredCharges
4599000 USD
CY2021Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-1038000 USD
CY2020Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-346000 USD
CY2021Q1 us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
-611000 USD
CY2020Q1 us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
539000 USD
CY2021Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
478000 USD
CY2020Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-974000 USD
CY2021Q1 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
3151000 USD
CY2020Q1 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
0 USD
CY2021Q1 lpro Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
140000 USD
CY2020Q1 lpro Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
66000 USD
CY2021Q1 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
112000 USD
CY2020Q1 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
116000 USD
CY2021Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
18835000 USD
CY2020Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
7075000 USD
CY2021Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
3000 USD
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
30414000 USD
CY2020Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
83000 USD
CY2021Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-3000 USD
CY2020Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-83000 USD
CY2021Q1 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
125000000 USD
CY2020Q1 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
170000000 USD
CY2021Q1 us-gaap Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
50000000 USD
CY2020Q1 us-gaap Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
0 USD
CY2021Q1 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
166847000 USD
CY2020Q1 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
3313000 USD
CY2021Q1 lpro Payments Of Deferred Financings Costs
PaymentsOfDeferredFinancingsCosts
1491000 USD
CY2020Q1 lpro Payments Of Deferred Financings Costs
PaymentsOfDeferredFinancingsCosts
9112000 USD
CY2021Q1 us-gaap Payments Of Dividends
PaymentsOfDividends
0 USD
CY2020Q1 us-gaap Payments Of Dividends
PaymentsOfDividends
134153000 USD
CY2021Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
6662000 USD
CY2020Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
23422000 USD
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
25494000 USD
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
104148000 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
9898000 USD
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
129642000 USD
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
40312000 USD
CY2021Q1 us-gaap Interest Paid Net
InterestPaidNet
2722000 USD
CY2020Q1 us-gaap Interest Paid Net
InterestPaidNet
89000 USD
CY2021Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
-16000 USD
CY2020Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
11000 USD
CY2021Q1 lpro Accrued Intangible Assets Costs
AccruedIntangibleAssetsCosts
463000 USD
CY2020Q1 lpro Accrued Intangible Assets Costs
AccruedIntangibleAssetsCosts
0 USD
CY2021Q1 lpro Accrued Deferred Financing Costs
AccruedDeferredFinancingCosts
178000 USD
CY2020Q1 lpro Accrued Deferred Financing Costs
AccruedDeferredFinancingCosts
0 USD
CY2021Q1 lpro Temporary Equity Fair Value Adjustment Of Redemption Option
TemporaryEquityFairValueAdjustmentOfRedemptionOption
0 USD
CY2020Q1 lpro Temporary Equity Fair Value Adjustment Of Redemption Option
TemporaryEquityFairValueAdjustmentOfRedemptionOption
-47537000 USD
CY2021Q1 lpro Accrued Distributions
AccruedDistributions
0 USD
CY2020Q1 lpro Accrued Distributions
AccruedDistributions
1228000 USD
CY2021Q1 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1 segment
CY2021Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2021Q1 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
Concentrations of revenue and credit risks<div style="margin-top:6pt;padding-left:27pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s business relationships with its two insurance partners generate 66% of the Company’s total revenue, with the top insurance partner accounting for approximately 65% of the total profit share revenue. In the event that one or more of our other significant customers terminate their relationships with us, or elect to utilize an alternative source for financing, the number of loans originated through the Lender’s Protection Platform (“LPP”) would decline, which would materially and adversely affect our business and, in turn, our revenue.</span></div><div style="margin-top:6pt;padding-left:27pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments that potentially subject the Company to credit risk consist of cash and cash equivalents, restricted cash and accounts receivable to the extent of the amounts recorded on the balance sheets.</span></div><div style="margin-top:6pt;padding-left:27pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash and cash equivalents are deposited in commercial analysis and savings accounts at two financial institutions, both with high credit standing. Restricted cash relates to funds held by the Company on behalf of the insurance carriers, delegated for the use of insurance claim payments. Restricted cash is deposited in commercial analysis accounts at one financial institution. At times, such deposits may be in excess of the Federal Deposit Insurance Corporation insurance limits of $250,000 per institution. The Company has not experienced any losses on its deposits of cash and cash equivalents and management believes the Company is not exposed to significant risks on such accounts.</span></div>The Company’s accounts receivables are derived from revenue earned from customers. The Company performs credit evaluations of its customers’ financial condition. As of March 31, 2021 and December 31, 2020, there was no allowance for doubtful accounts. At March 31, 2021, the Company had one customer that represented 17% of the Company's accounts receivable. At December 31, 2020, the Company had one customer that represented 19% of the Company’s accounts receivable.
CY2021Q1 us-gaap Use Of Estimates
UseOfEstimates
Use of estimates and judgments<div style="margin-top:6pt;padding-left:27pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts in the condensed consolidated financial statements and accompanying notes. Actual results could differ from those estimates, and those differences may be material. Estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to estimates are recognized prospectively.</span></div><div style="margin-top:6pt;padding-left:27pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The most significant items subject to such estimates and assumptions include, but are not limited to, profit share revenue recognition and the corresponding impact on contract assets, the recognition of the valuations of share-based compensation arrangements, and assessing the realizability of deferred tax assets. These estimates, although based on actual historical trend and modeling, may potentially show significant variances over time.</span></div><div style="margin-top:6pt;padding-left:27pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with profit share revenue recognition and the estimation of contract asset under Accounting Standards Update (“ASU”) 2014-9, Revenue from Contracts with Customers (Topic 606) (“ASC 606”), we use forecasts of loan-level earned premium and insurance claim payments. These forecasts are driven by the projection of loan defaults, prepayments and default severity rates. These assumptions are based on our observations of the historical behavior for loans with similar risk characteristics. The assumptions also take into consideration the forecast adjustments under various macroeconomic conditions, including the potential impact from the COVID-19 pandemic, and the current mix of the underlying portfolio of our insurance partners. As the Company closely monitors the development of the pandemic and its ongoing impact on Open Lending's business, management has accordingly adjusted these assumptions during the first three months of 2021 as a result of changes in facts and circumstances and general market conditions derived from the COVID-19 pandemic.</span></div>
CY2021Q1 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
1663000 USD
CY2020Q4 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
9066000 USD
CY2021Q1 us-gaap Long Term Debt
LongTermDebt
173337000 USD
CY2020Q4 us-gaap Long Term Debt
LongTermDebt
157747000 USD
CY2021Q1 us-gaap Long Term Debt Current
LongTermDebtCurrent
3125000 USD
CY2020Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
4888000 USD
CY2021Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
170212000 USD
CY2020Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
152859000 USD
CY2021Q1 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-8800000 USD
CY2020Q4 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
89342000 USD
CY2021Q1 us-gaap Contract With Customer Asset Increase Decrease For Contract Acquired In Business Combination
ContractWithCustomerAssetIncreaseDecreaseForContractAcquiredInBusinessCombination
38934000 USD
CY2021Q1 us-gaap Contract With Customer Asset Cumulative Catch Up Adjustment To Revenue Change In Measure Of Progress
ContractWithCustomerAssetCumulativeCatchUpAdjustmentToRevenueChangeInMeasureOfProgress
-5074000 USD
CY2021Q1 us-gaap Contract With Customer Asset Reclassified To Receivable
ContractWithCustomerAssetReclassifiedToReceivable
14860000 USD
CY2021Q1 lpro Payments Received From Insurance Carriers
PaymentsReceivedFromInsuranceCarriers
21272000 USD
CY2021Q1 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
52700000 USD
CY2021Q1 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
97218000 USD
CY2020Q4 us-gaap Contract With Customer Asset Net Noncurrent
ContractWithCustomerAssetNetNoncurrent
39000000.0 USD
CY2020Q4 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
50400000 USD
CY2021Q1 us-gaap Contract With Customer Asset Net Noncurrent
ContractWithCustomerAssetNetNoncurrent
44500000 USD
CY2021Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
701000 USD
CY2020Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
487000 USD
CY2021Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
701000 USD
CY2020Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
487000 USD
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
199764 shares
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
33.56
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0 shares
CY2021Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0
CY2021Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0 shares
CY2021Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
0 shares
CY2021Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
0
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
199764 shares
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
33.56
CY2021Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
8666000 USD
CY2021Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P3Y2M19D
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
12862000 USD
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
8172000 USD
CY2021Q1 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
0 USD
CY2020Q1 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
40475000 USD
CY2021Q1 lpro Noncash Adjustment To Redemption Amount Of The Redeemable Convertible Preferred Units
NoncashAdjustmentToRedemptionAmountOfTheRedeemableConvertiblePreferredUnits
0 USD
CY2020Q1 lpro Noncash Adjustment To Redemption Amount Of The Redeemable Convertible Preferred Units
NoncashAdjustmentToRedemptionAmountOfTheRedeemableConvertiblePreferredUnits
-47537000 USD
CY2021Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
12862000 USD
CY2020Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
15234000 USD
CY2021Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
126803096 shares
CY2020Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
37631052 shares
CY2021Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.10
CY2020Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.40
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
12862000 USD
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
8172000 USD
CY2021Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
126803096 shares
CY2020Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
37631052 shares
CY2021Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
34736 shares
CY2020Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0 shares
CY2021Q1 us-gaap Incremental Common Shares Attributable To Conversion Of Preferred Stock
IncrementalCommonSharesAttributableToConversionOfPreferredStock
0 shares
CY2020Q1 us-gaap Incremental Common Shares Attributable To Conversion Of Preferred Stock
IncrementalCommonSharesAttributableToConversionOfPreferredStock
14278603 shares
CY2021Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
126837832 shares
CY2020Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
51909655 shares
CY2021Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.10
CY2020Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.16
CY2021Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
299053000 shares
CY2020Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0 shares
CY2021Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
4500000 USD
CY2020Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
11000.0 USD
CY2021Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.258
CY2020Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.001
CY2020Q1 us-gaap Due From Related Parties
DueFromRelatedParties
6000000.0 USD
CY2021Q1 us-gaap Due From Related Parties
DueFromRelatedParties
0 USD

Files In Submission

Name View Source Status
0001628280-21-010361-index-headers.html Edgar Link pending
0001628280-21-010361-index.html Edgar Link pending
0001628280-21-010361.txt Edgar Link pending
0001628280-21-010361-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
lpro-20210331.htm Edgar Link pending
lpro-20210331.xsd Edgar Link pending
lpro-20210331ex311.htm Edgar Link pending
lpro-20210331ex312.htm Edgar Link pending
lpro-20210331ex321.htm Edgar Link pending
lpro-20210331ex322.htm Edgar Link pending
lpro-20210331_cal.xml Edgar Link unprocessable
lpro-20210331_def.xml Edgar Link unprocessable
lpro-20210331_g1.jpg Edgar Link pending
lpro-20210331_htm.xml Edgar Link completed
lpro-20210331_lab.xml Edgar Link unprocessable
lpro-20210331_pre.xml Edgar Link unprocessable
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending